Seven-day contraceptive patch: Completed Phase III enrollment

Agile completed enrollment of 1,500 women in the open-label, U.S. Phase III NEW CHOICE trial to compare AG200-15 vs. low-dose oral contraceptives. Subjects will apply the 7-day patch once weekly for 3...